Erectile dysfunction and cavernosal endothelial cells;Dysfonction érectile et cellules endothéliales caverneuses

Progres en Urologie

Volumn 20, Issue 3, 2010, Pages 188-193

  Galiano, M ^a   Pignot, G ^b,e   Costa, C ^d   Vallancien, G ^a   Virag, R ^c  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

^b Assistance publique Hôpitaux de Paris ^*  (France)

^c Centre d'Explorations et Traitements de l'Impuissance   (France)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Endothelial dysfunction; Erectile dysfunction; Vascular risk factors

Indexed keywords

CYTOLOGY; ENDOTHELIUM CELL; HUMAN; MALE; ORGANIC IMPOTENCE; PHYSIOLOGY; RISK FACTOR; SHORT SURVEY; VASCULAR ENDOTHELIUM;

ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMPOTENCE, VASCULOGENIC; MALE; RISK FACTORS;

EID: 77949272145     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2009.07.009     Document Type: Short Survey

References (37)

1. Lerman A., and Burnett Jr. J.C. Intact and altered endothelium in regulation of vasomotion. Circulation 86 (1992) III12-III19
2. Esper R.J., Nordaby R.A., Vilarino J.O., Paragano A., Cacharron J.L., and Machado R.A. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol 5 (2006) 4
3. Villar I.C., Francis S., Webb A., Hobbs A.J., and Ahluwalia A. Novel aspects of endothelium-dependent regulation of vascular tone. Kidney Int 70 (2006) 840-853
4. Endemann D.H., and Schiffrin E.L. Endothelial dysfunction. J Am Soc Nephrol 15 (2004) 1983-1992
5. Burnett A.L., Lowenstein C.J., Bredt D.S., Chang T.S., and Snyder S.H. Nitric oxide: a physiologic mediator of penile erection. Science 257 (1992) 401-403
6. Andersson K.E. Pharmacology of penile erection. Pharmacol Rev 53 (2001) 417-450
7. Hedlund P., Szodi A., Pfeifer A., Alm P., Hofman F., Ahmas M., et al. Erectile dysfunction in cyclic GMP-dependent kinase-I-deficient mice. Proc Natl Acad Sci U S A 97 (2000) 2349-2354
8. Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol 155 (1996) 802-815
9. Virag R., Ottesen B., Levy C., and Wagner G. Vasoactive intestinal polypeptide release during penile erection in man. Lancet 2 (1982) 1166
10. Chaiban J.T., and Azar S.T. Erectile dysfunction in diabetic patients. J Med Liban 52 (2004) 217-219
11. Musicki B., Kramer M.F., Becker R.E., and Burnett A.L. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A 102 (2005) 11870-11875
12. Jesmin S., Sakuma I., Salah-Eldin A., Nonomura K., Hattori Y., and Kitabatake A. Diminished penile expression of vascular endothelial growth factor and its receptors at the insulin-resistant stage of a type II diabetic rat model: a possible cause for erectile dysfunction in diabetes. J Mol Endocrinol 31 (2003) 401-418
13. Bivalacqua T.J., Usta M.F., Kendirci M., Pradhan L., Alvarez X., Champion H.C., et al. Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med 2 (2005) 187-197
14. Morano S., Gatti A., Mandosi E., Tiberti C., Fallarino M., Cipriani R., et al. Circulating monocyte oxidative activity is increased in patients with type 2 diabetes and erectile dysfunction. J Urol 177 (2007) 655-659
15. De Young L., Yu D., Bateman R.M., and Brock G.B. Oxidative stress and antioxidant therapy: their impact in diabetes-associated erectile dysfunction. J Androl 25 (2004) 830-836
16. Bivalacqua T.J., Usta M.F., Champion H.C., Adams D., Namara D.B., Abdel-Mageed A.B., et al. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol 169 (2003) 1911-1917
17. Shirai M., Yamanaka M., Shiina H., Igawa M., Kawakami T., Ishii N., et al. Vascular endothelial growth factor restores erectile function through modulation of the insulin-like growth factor system and sex hormone receptors in diabetic rat. Biochem Biophys Res Commun 341 (2006) 755-762
18. Yamanaka M., Shirai M., Shiina H., Tanaka Y., Enokida H., Tsujimura A., et al. Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol 173 (2005) 318-323
19. Seftel A.D., Maclennan G.T., Chen Z.J., Liu S., Ferguson K., Deoreo G., et al. Loss of TGFbeta, apoptosis, and Bcl-2 in erectile dysfunction and upregulation of p53 and HIF-1alpha in diabetes-associated erectile dysfunction. Mol Urol 3 (1999) 103-107
20. Esposito K., Ciotola M., Giugliano F., Sardelli L., Giugliano F., Maiorino M.I., et al. Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction. J Sex Med 5 (2008) 1436-1442
21. Costa C., Soares R., Castela A., Adaes S., Hastert V., Vendeira P., et al. Increased endothelial apoptotic cell density in human diabetic erectile tissue - comparison with clinical data. J Sex Med 6 (2008) 826-835
22. Jensen J., Lendorf A., Stimpel H., Frost J., Ibsen H., and Rosenkilde P. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 12 (1999) 271-275
23. Ushiyama M., Morita T., Kuramochi T., Yagi S., and Katayama S. Erectile dysfunction in hypertensive rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide. Hypertens Res 27 (2004) 253-261
24. Jin L., Lagoda G., Leite R., Webb R.C., and Burnett A.L. NADPH oxidase activation: a mechanism of hypertension-associated erectile dysfunction. J Sex Med 5 (2008) 544-551
25. Ushiyama M., Kuramochi T., Yagi S., and Katayama S. Antioxidant treatment with alpha-tocopherol improves erectile function in hypertensive rats. Hypertens Res 31 (2008) 1007-1013
26. Feldman H.A., Johannes C.B., Derby C.A., Kleinman K.P., Mohr B.A., Araujo A.B., et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachussetts male aging study. Prev Med 30 (2000) 328-338
27. Xie D., Odronic S.I., Wu F., Pippen A.M., Donatucci C.F., and Annex B.H. A mouse model of hypercholesterolemia-induced erectile dysfunction. J Sex Med 4 (2007) 898-907
28. Seo K.K., Yun H.Y., Kim H., and Kim S.C. Involvement of endothelial nitric oxide synthase in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbits. J Androl 20 (1999) 298-306
29. Zouaoui Boudjeltia K., Roumeguere T., Delree P., Moguilevsky N., Ducobu J., Vanhaeverbeek M., et al. Presence of LDL modified by myeloperoxidase in the penis in patients with vascular erectile dysfunction: a preliminary study. Eur Urol 51 (2007) 262-268
30. Ryu J.K., Shin H.Y., Song S.U., Oh S.M., Piao S., Han J.Y., et al. Downregulation of angiogenic factors and their downstream target molecules affects the deterioration of erectile function in a rat model of hypercholesterolemia. Urology 67 (2006) 1329-1334
31. Byrne R.R., Henry G.D., Rao D.S., Huynh T.T., Pippen A.M., Annex B.H., et al. Vascular endothelial growth factor restores corporeal smooth muscle function in vitro. J Urol 165 (2001) 1310-1315
32. Ryu J.K., Cho C.H., Shin H.Y., Song S.U., Oh S.M., Lee M., et al. Combinated angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia. Mol Ther 13 (2006) 705-715
33. Giuliano F., Chevret-Measson M., Tsatsaris A., Reitz C., Murino M., and Thonneau P. Prévalence de la dysfonction érectile en France : résultats d'une étude épidémiologique réalisée sur un échantillon représentatif de 1004 hommes. Prog Urol 12 (2002) 260-267
34. Champion H.C., Bivalacqua T.J., Hyman A.L., Ignarro L.J., Hellstrom W.J., and Kadowitz P.J. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci U S A 96 (1999) 11648-11652
35. Rajasekaran M., Kasyan A., Jain A., Kim S.W., and Monga M. Altered growth factor expression in the aging penis: the Brown-Norway rat model. J Androl 23 (2002) 393-399
36. Bivalacqua T.J., Armstrong J.S., Biggerstaff J., Abdel-Mageed A.B., Kadowitz P.J., Hellstrom W.J., et al. Gene transfer of extracellular SOD to the penis reduces O2-* and improves erectile function in aged rats. Am J Physiol Heart Circ Physiol 284 (2003) H1408-H1421
37. Bivalacqua T.J., Burnett A.L., Hellstrom W.J., and Champion H.C. Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase. Am J Physiol Heart Circ Physiol 292 (2007) H1340-H1351